Abstract |
The purpose of this study was to develope and characterize a micellar formulations of N-{[(2-hydroxy-5- nitrophenyl)amino]carbonothioyl}-3,5-dimethylbenzamide (DM-PIT-1)-a new small molecule non- lipid antagonist of phopshotidylinositol-3.4.5-triphopshate and inhibitor of the PI3-kinase pathway. Micelle-forming PEG(2000)-PE was used to solubilize DM-PIT-1. To improve the specificity of the micellar DM-PIT-1, cancer-targeting anti-nucleosomal mAb2C5 antibodies as well as Tumor necrosis factor- Related Apoptosis-Inducing Ligand (TRAIL) were attached to the surface of polymeric micelles. DM-PIT-1 was effectively incorporated (> 70%) into 14-16 nm micelles, which had a negative surface zeta potential of 4-5 mV. Micellar DM-PIT-1 demonstrated high in vitro cytotoxicity against various cancer cells. An improved potency of the dual-activity DM-PIT-1/TRAIL combination nanoparticles in inducing death of TRAIL-resistant cancer cells was shown. Efficacy of the TRAIL therapy was enhanced by combining it with the 2C5 antibody cancer-targeted micellar form of DM-PIT-1. In conclusion, DM-PIT-1 micellar preparations can be used for targeted combination therapy against TRAIL-resistant cancers.
|
Authors | Igor Skidan, Benchun Miao, Ritesh V Thekkedath, Parita Dholakia, Alexei Degterev, Vladimir Torchilin |
Journal | Drug delivery
(Drug Deliv)
Vol. 16
Issue 1
Pg. 45-51
(Jan 2009)
ISSN: 1521-0464 [Electronic] England |
PMID | 19555308
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antibodies, Monoclonal
- Antineoplastic Agents
- Benzamides
- Drug Carriers
- Micelles
- N-(((2-hydroxy-5-nitrophenyl)amino)carbonothioyl)-3,5-dimethylbenzamide
- Phosphatidylethanolamines
- Phosphatidylinositol Phosphates
- Phosphoinositide-3 Kinase Inhibitors
- TNF-Related Apoptosis-Inducing Ligand
- phosphatidylinositol 3,4,5-triphosphate
- dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamine
- Polyethylene Glycols
|
Topics |
- Animals
- Antibodies, Monoclonal
(administration & dosage, chemistry)
- Antineoplastic Agents
(administration & dosage, chemistry, pharmacology)
- Apoptosis
(drug effects)
- Benzamides
(administration & dosage, chemistry, pharmacology)
- Cell Line, Tumor
- Drug Carriers
(chemistry)
- Drug Delivery Systems
- Drug Resistance, Neoplasm
- Humans
- Mice
- Micelles
- Nanoparticles
- Neoplasms
(drug therapy)
- Phosphatidylethanolamines
(chemistry)
- Phosphatidylinositol Phosphates
(antagonists & inhibitors)
- Phosphoinositide-3 Kinase Inhibitors
- Polyethylene Glycols
(chemistry)
- Solubility
- TNF-Related Apoptosis-Inducing Ligand
(administration & dosage, chemistry, metabolism)
|